JHS Svendgaard Laboratories Revises Preferential Issue Fund Utilization Plan
Published on: June 26, 2026, 3:06 a.m. | Source: scanx.trade
JHS Svendgaard Laboratories' Board approved a variation in the utilization of ₹2,999.99 lakh raised through a preferential issue, subject to shareholder approval. The revised plan reallocates funds into Capital Expenditure and Business Expansion (₹1,174.99 lakh), Strategic, Financial and Growth Initiatives (₹1,075.00 lakh), and General Corporate Purpose (₹750.00 lakh), extending the utilization timeline to March 31, 2027.
